$50.7 Million is the total value of Healthcare Value Capital, LLC's 25 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 34.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Sell | GILEAD SCIENCES INC | $4,191,000 | -18.9% | 60,000 | -20.0% | 8.27% | -19.6% |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $3,821,000 | -4.0% | 100,000 | 0.0% | 7.54% | -4.9% | |
| PFE | Sell | PFIZER INC | $3,226,000 | -17.6% | 75,000 | -25.0% | 6.37% | -18.4% |
| ALKS | Sell | ALKERMES PLC | $3,084,000 | -16.2% | 100,000 | -33.3% | 6.09% | -16.9% |
| ALKS | New | ALKERMES PLCput | $3,084,000 | – | 100,000 | +100.0% | 6.09% | – |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $3,023,000 | +24.6% | 250,000 | +25.0% | 5.97% | +23.5% |
| MRK | MERCK & CO INC | $3,004,000 | -3.4% | 40,000 | 0.0% | 5.93% | -4.3% | |
| AZN | ASTRAZENECA PLCsponsored adr | $3,003,000 | +0.3% | 50,000 | 0.0% | 5.93% | -0.7% | |
| BMY | BRISTOL-MYERS SQUIBB CO | $2,959,000 | -11.4% | 50,000 | 0.0% | 5.84% | -12.2% | |
| SPXU | Buy | PROSHARES TRcall | $2,631,000 | +188.8% | 150,000 | +200.0% | 5.19% | +186.2% |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $2,612,000 | +1.5% | 200,000 | 0.0% | 5.16% | +0.5% | |
| CLVS | CLOVIS ONCOLOGY INC | $2,230,000 | -23.1% | 500,000 | 0.0% | 4.40% | -23.8% | |
| PFE | New | PFIZER INCput | $2,151,000 | – | 50,000 | +100.0% | 4.25% | – |
| TYME | Buy | TYME TECHNOLOGIES INC | $2,060,000 | +9.0% | 2,000,000 | +33.3% | 4.07% | +8.0% |
| ATRS | ANTARES PHARMA INC | $1,820,000 | -16.5% | 500,000 | 0.0% | 3.59% | -17.3% | |
| SQQQ | Buy | PROSHARES TRcall | $1,726,000 | +88.8% | 200,000 | +100.0% | 3.41% | +87.1% |
| UVXY | New | PROSHARES TR IIcall | $1,228,000 | – | 50,000 | +100.0% | 2.42% | – |
| AMRN | AMARIN CORP PLCcall | $1,020,000 | +16.4% | 200,000 | 0.0% | 2.01% | +15.4% | |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $907,000 | – | 5,000 | +100.0% | 1.79% | – |
| GNLN | GREENLANE HLDGS INCcl a | $830,000 | -47.0% | 350,000 | 0.0% | 1.64% | -47.4% | |
| VYNE | Sell | VYNE THERAPEUTICS INC | $556,000 | -64.8% | 400,000 | -11.1% | 1.10% | -65.1% |
| ADMS | ADAMAS PHARMACEUTICALS INC | $491,000 | -7.0% | 100,000 | 0.0% | 0.97% | -7.9% | |
| GMDA | Buy | GAMIDA CELL LTD | $392,000 | -18.5% | 100,000 | +33.3% | 0.77% | -19.2% |
| DRRX | New | DURECT CORP | $320,000 | – | 250,000 | +100.0% | 0.63% | – |
| VIXY | Sell | PROSHARES TR IIcall | $285,000 | -52.7% | 12,500 | -50.0% | 0.56% | -53.1% |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INCcall | $0 | – | -50,000 | -100.0% | -1.28% | – |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -125,000 | -100.0% | -3.12% | – |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -100,000 | -100.0% | -4.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.